Completed PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT00732953

Prevention of Restenosis After Genous Stent Implantation Using a Paclitaxel Eluting Balloon in Coronary Arteries

Prevention of Restenosis After Genous Stent Implantation Using a Paclitaxel Eluting Balloon in Coronary Arteries - a Randomized Clinical Trial.

Sponsor: B. Braun Melsungen AG

Conditions Coronary Artery Disease

Interventions Genous stent implantation Genous stent implantation with paclitaxel-eluting balloon dilation

Updated 5 times since 2017 Last updated: Jun 7, 2014 Started: Feb 28, 2009 Primary completion: Jan 31, 2010 Completion: Feb 28, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00732953, this PHASE2/PHASE3 trial focuses on Coronary Artery Disease and remains completed. Sponsored by B. Braun Melsungen AG, it has been updated 5 times since 2009, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2_PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2_PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2_PHASE3

First recorded

Feb 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

B. Braun Melsungen AG
OrbusNeich
University of Ulm

Data source: University of Ulm

For direct contact, visit the study record on ClinicalTrials.gov .

Prevention of Restenosis After Genous Stent Implantation Using a Paclitaxel Eluting Balloon in Coronary Arteries

Status Flow

Change History

Eligibility Summary

Contact Information

Study Locations

Related Trials